These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7755343)

  • 21. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes.
    Stowasser M; Gartside MG; Taylor WL; Tunny TJ; Gordon RD
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3670-6. PubMed ID: 9360524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism.
    Jamieson A; Murdoch D; Kennedy JA; Connell JM
    J Hypertens; 1995 May; 13(5):551-6. PubMed ID: 7561013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular basis of glucocorticoid-remediable aldosteronism, a Mendelian cause of human hypertension.
    Lifton RP; Dluhy RG; Powers M; Ulick S; Lalouel JM
    Trans Assoc Am Physicians; 1992; 105():64-71. PubMed ID: 1309006
    [No Abstract]   [Full Text] [Related]  

  • 24. Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism.
    Jamieson A; Ingram MC; Inglis GC; Davies E; Fraser R; Connell JM
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2298-302. PubMed ID: 8964867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
    Mussa A; Camilla R; Monticone S; Porta F; Tessaris D; Verna F; Mulatero P; Einaudi S
    Endocr J; 2012; 59(6):497-502. PubMed ID: 22447138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial hyperaldosteronism].
    Spoto B; Furlò G; Gervasi A; Bresolin G; Zoccali C
    G Ital Nefrol; 2004; 21(2):139-43. PubMed ID: 15351948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.
    Lifton RP; Dluhy RG; Powers M; Rich GM; Cook S; Ulick S; Lalouel JM
    Nature; 1992 Jan; 355(6357):262-5. PubMed ID: 1731223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism.
    Ganguly A; Grim CE; Weinberger MH
    N Engl J Med; 1981 Oct; 305(17):991-3. PubMed ID: 6268979
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary aldosteronism: hypertension with a genetic basis.
    Gordon RD; Klemm SA; Tunny TJ; Stowasser M
    Lancet; 1992 Jul; 340(8812):159-61. PubMed ID: 1352575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations.
    Ganguly A; Grim CE; Bergstein J; Brown RD; Weinberger MH
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1040-6. PubMed ID: 7026592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid remediable aldosteronism: a rare hereditary form of adrenocorticotropic hormone regulated mineralocorticoid hypertension.
    Comiter CV; Capelouto CC; Tobin MS; Dluhy RG; Richie JP
    J Urol; 1995 Aug; 154(2 Pt 1):510-2. PubMed ID: 7609119
    [No Abstract]   [Full Text] [Related]  

  • 33. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
    Stowasser M; Gordon RD; Klemm SA; Tunny TJ
    J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting hypertension: the role of the 'new genetics'.
    Jamieson A
    J R Coll Physicians Lond; 1994; 28(6):512-8. PubMed ID: 7884706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Williams GH
    Cardiovasc Res; 1996 Jun; 31(6):870-2. PubMed ID: 8759241
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mineralocorticoids and hypertension].
    Glorioso N; Soro A
    Cardiologia; 1998 Mar; 43(3):241-51. PubMed ID: 9611851
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Lifton RP
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, biochemical and genetic features of five extended kindred's with glucocorticoid-suppressible hyperaldosteronism.
    Jamieson A; Slutsker L; Inglis G; Campbell M; Fraser R; White P; Connell J
    Endocr Res; 1995; 21(1-2):463-9. PubMed ID: 7588411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
    Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.